NORMA Group SE
NORMA Group SE (NOEJ.SW) Financial Performance & Income Statement Overview
Explore the financials of NORMA Group SE (NOEJ.SW), including yearly and quarterly data on income, cash flow, and balance sheets.
NORMA Group SE (NOEJ.SW) Income Statement & Financial Overview
Review NORMA Group SE NOEJ.SW income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $266.76M | $273.56M | $306.30M | $308.54M |
| Cost of Revenue | $110.14M | $224.93M | $251.56M | $132.43M |
| Gross Profit | $156.62M | $48.63M | $54.74M | $176.11M |
| Gross Profit Ratio | $0.59 | $0.18 | $0.18 | $0.57 |
| R&D Expenses | $0.00 | $0.00 | $28.20M | $0.00 |
| SG&A Expenses | $0.00 | $35.66M | $37.52M | $40.32M |
| Operating Expenses | $155.74M | $34.85M | $285.80M | $155.67M |
| Total Costs & Expenses | $265.88M | $258.04M | $285.80M | $288.10M |
| Interest Income | $720000.00 | $1.13M | $1.24M | $1.14M |
| Interest Expense | $6.81M | $6.41M | $6.70M | $6.78M |
| Depreciation & Amortization | $35.49M | $19.99M | $6.50M | $19.97M |
| EBITDA | $38.04M | $36.63M | $42.87M | $37.65M |
| EBITDA Ratio | $0.14 | $0.13 | $0.14 | $0.12 |
| Operating Income | $885000.00 | $15.52M | $20.50M | $20.44M |
| Operating Income Ratio | $0.003 | $0.06 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$5.14M | -$5.28M | -$6.71M | -$6.17M |
| Income Before Tax | -$4.26M | $10.24M | $13.77M | $14.27M |
| Income Before Tax Ratio | -$0.02 | $0.04 | $0.04 | $0.05 |
| Income Tax Expense | $2.07M | $4.13M | -$6.50M | $5.82M |
| Net Income | -$6.30M | $6.11M | $6.49M | $8.41M |
| Net Income Ratio | -$0.02 | $0.02 | $0.02 | $0.03 |
| EPS | -$0.20 | $0.19 | $0.20 | $0.26 |
| Diluted EPS | -$0.20 | $0.19 | $0.20 | $0.26 |
| Weighted Avg Shares Outstanding | $31.86M | $32.13M | $32.35M | $32.35M |
| Weighted Avg Shares Outstanding (Diluted) | $31.86M | $32.13M | $32.35M | $32.35M |
The company's financials show resilient growth, with revenue advancing from $308.54M in Q1 2024 to $266.76M in Q4 2024. Gross profit remained healthy with margins at 59% in Q4 2024 compared to 57% in Q1 2024. Operating income hit $885000.00 last quarter, sustaining a consistent 0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $38.04M. Net income dropped to -$6.30M, while earnings per share reached -$0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan